Stocks/Health Care/Health Care Equipment

StrykerSYK

Health Care Equipment · Kalamazoo, Michigan · In the S&P 500

Solid business

$291.86−6.38%After hours: $293.00 (+0.39%)At the close, 30 Oct · Prices from CNBC, may be delayed

▼ 21.0% over 1 year

Stryker over 1 yearDaily close, $, to 30 Oct 2026

Source: Nasdaq daily closes

Market value$112B

Price to earnings31.1x

Forward P/E18.4x

Dividend yield1.21%

Year to date−17.0%

One year−21.0%

Next earningsNot scheduled

SectorHealth Care

52-week range (closes)

$269.75$387.46

Quality and valuation

How Stryker compares with other health care stocks. A description, not a recommendation.

Stronger business ↑↓ Weaker business← Pricier · 37x14x · Cheaper →Stronger, pricierStronger, cheaperWeaker, pricierWeaker, cheaper

ABT

ISRG

MDT

BSX

BDX

IDXX

SYK

Stryker and 7 health care equipment peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Business quality: about averageValuation: in line with its sector

An average business among health care companies, priced about in line with them.

Stryker trades at 18.4 times the next 12 months of expected earnings, against a median of 19.1x for the 65 health care stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.

Revenue grew faster than the sector median: +7.9% vs +7.8%
Keeps less of each sale (gross margin): 65.3% vs 65.3%
More profitable (operating margin): 20.7% vs 13.3%
Turns more of its sales into cash: 17.4% vs 15.9%

SYK trades at 18.4x forward earnings, below the sector medianForward p/e, Health Care Equipment peers

Source: CNBC quotes; Mostly Markets

At 31.1x earnings, SYK is cheaper than its average since Oct 2024Price over the last 12 months of reported (GAAP) diluted EPS

P/EUsual range (±1 s.d.)

Source: Nasdaq prices; SEC filings

Financials

From Stryker's SEC filings, through the quarter ending 30 Sep 2026. Hover or tap a bar for its value.

Revenue grew 7.6% from a year earlierQuarterly revenue, $bn, latest Q3 ’26

Source: SEC filings

Growth slowed to +7.6% last quarterRevenue growth, year on year, %

Source: SEC filings

Operating margin was 15.9% last quarterOperating income as a share of revenue, %

Source: SEC filings

Free cash flow was $4.6 billion over 12 monthsQuarterly free cash flow (operating cash flow minus capex), $bn

Source: SEC filings

Last 12 months	SYK	Sector median
Revenue growth	+7.9%	+7.8%
Gross margin	65.3%	65.3%
Operating margin	20.7%	13.3%
Free cash flow margin	17.4%	15.9%
Price to earnings	31.1x	30.2x

Stories on Stryker

Friday, 30 October

Earnings11:23 a.m. ET

Stryker (SYK) Misses Q3 Estimates as Hip and Knee Procedures Slow

Stryker's revenue rose 7.7% to $6.52 billion, short of the $6.58 billion expected, and it cut its 2026 growth forecast. The stock was down 7.6% Friday morning.

SYK▲ 2.5%11:23 a.m. ET

An artificial knee joint beside an hourglass on a hospital tray

Thursday, 29 October

Big movers5:21 p.m. ET

Stocks Making the Biggest Moves After Hours: Intel, Reddit, Stryker, Pinterest and Amazon

Intel plunged 19.6% after hours on a weak forecast, Reddit 16.7% on soft guidance and a traffic warning, and Amazon slid 6.5% after missing on earnings per share and ads.

INTC▼ 19.6%AH5:21 p.m. ET

Similar companies

Health Care Equipment, by market value.

Company	Price	Today	YTD	Value
ABTAbbott Laboratories	$106.20	+1.56%	−15.2%	$184B
ISRGIntuitive Surgical	$432.01	−3.73%	−23.7%	$150B
MDTMedtronic	$96.54	−0.59%	+0.5%	$123B
BSXBoston Scientific	$41.98	−1.66%	−56.0%	$60.84B
BDXBecton Dickinson	$197.88	−0.23%	+27.4%	$53.90B
EWEdwards Lifesciences	$92.01	−2.57%	+7.9%	$53.03B
IDXXIdexx Laboratories	$551.21	−4.30%	−18.5%	$43.42B
GEHCGE HealthCare	$76.57	+0.20%	−6.6%	$34.62B